Hyo Jeong Lee

Prof. Dr. Hyo Jeong Lee

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2021 in Gut and Liver
Verified
Journal Article
Open access
PDF file
JLJin Wook Lee
Jin Wook Lee
HLHyo Jeong Lee
Hyo Jeong Lee
DKDae Sung Kim
Dae Sung Kim
JYJiyoung Yoon
Jiyoung Yoon
SHSeung Wook Hong
Seung Wook Hong
JBJeong-Sik Byeon
Jeong-Sik Byeon
Jin Wook Lee, Hyo Jeong Lee, Dae Sung Kim, Jiyoung Yoon, Seung Wook Hong, Ha Won Hwang, Jong-Soo Lee, Gwang-Un Kim, Sinwon Lee, Jaewon Choe, Jin Hwa Park, Dong-Hoon Yang, and Jeong-Sik Byeon. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl210063

18 July 2025 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HPHana Park
Hana Park
JLJI YOUNG LEE
JI YOUNG LEE
SPSungwon Park
Sungwon Park
HLHyo Jeong Lee
Hyo Jeong Lee
SBSuh Eun Bae
Suh Eun Bae
JSJu Hyun Shim
Ju Hyun Shim
Hana Park, Ji Young Lee, Sungwon Park, Hyo Jeong Lee, Suh Eun Bae, Jaeil Kim, Hye-Sook Chang, Jaewon Choe, Hye Won Park, Ju Hyun Shim. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250053

29 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
HLHyo Jeong Lee
Hyo Jeong Lee
JOJi Seon Oh
Ji Seon Oh
SKSehee Kim
Sehee Kim
SPSung Won Park
Sung Won Park
DODongwook Oh
Dongwook Oh
JLJI YOUNG LEE
JI YOUNG LEE
Background/Objectives: Early detection of pancreatic cancer (PC) remains challenging due to the lack of effective screening tools. We aimed to develop a clinically applicable model to identify individuals at high risk of PC using routine health check-up data. Methods: In a 1:4 matched case–control study (111 cases and 439 controls) using data collected between 2010 and 2018, PC cases were defined as individuals diagnosed with PC within 2 years of a health check-up. A model was developed using conditional logistic regression and validated in an independent cohort of 52,043 individuals (40 PC cases; 2019–2021). Results: Five risk factors were identified: carbohydrate antigen 19-9 ≥ 39 U/mL, hemoglobin A1c ≥ 6.5%, alkaline phosphatase > 110 IU/L, weight loss ≥ 5%, and dyspepsia. A 12-point risk scoring system was constructed, with an area under the curve of 0.784 in the development and 0.841 in the validation cohort. At a threshold of ≥5, the high-risk group had a significantly higher 2-year incidence of PC than the low-risk group (2.56% vs. 0.047%; p < 0.001), a 54.76-fold risk enrichment, with a negative predictive value of 99.95% and a number-needed-to-follow of 39. Conclusions: This simple, validated model effectively stratifies short-term PC risk using routine data, potentially facilitating targeted surveillance in the general population.